Screener
Monte Rosa Therapeutics, Inc. GLUE Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Monte Rosa Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:09 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336711
| (in thousands, except share and per share amounts) | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Foreign currency exchange gain | 25 | 1,390 | 17 | 1,563 |
| Gain on disposal of property and equipment | — | — | — | 59 |
| Total other income | 5,941 | 4,458 | 11,524 | 8,129 |
| Net (loss) income before income taxes | (43,189) | (11,096) | (87,640) | 36,611 |
| Income tax provision | (208) | (1,199) | (260) | (2,021) |
| Net (loss) income | $(43,397) | $(12,295) | $(87,900) | $34,590 |
| Comprehensive (loss) income: | ||||
| Provision for pension benefit obligation | 54 | 53 | 109 | 101 |
Item 1. Financial Statements
FAQ
- What is Monte Rosa Therapeutics, Inc.'s pre-tax income?
- Monte Rosa Therapeutics, Inc. (GLUE) reported pre-tax income of -$43.19M in Q2 2026.
- How has Monte Rosa Therapeutics, Inc.'s pre-tax income changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s pre-tax income decreased by 289.2% year-over-year, from -$11.1M to -$43.19M.
- What is the long-term trend for Monte Rosa Therapeutics, Inc.'s pre-tax income?
- Over 2 years (2022 to 2025), Monte Rosa Therapeutics, Inc.'s pre-tax income has grown at a -39.5% compound annual growth rate (CAGR), from -$108.5M to -$39.72M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Monte Rosa Therapeutics, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude